Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Acta Otorhinolaryngol Ital ; 36(3): 174-84, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27070541

ABSTRACT

The objective of this study is to report the initial results of a prospective trial assessing instrumental deglutition function in nasopharynx and oropharynx cancers after radio or chemoradiotherapy using intensity-modulated radiotherapy (IMRT). IMRT was delivered aiming to spare the swallowing organ at risk (SWOARs) for Stage II-IV naso- and oropharynx cancer. Objective instrumental assessment included videofluoroscopy (VFS), fiberoptic endoscopic evaluation of swallowing (FEES) and oro-pharyngeal-oesophageal scintigraphy (OPES) at baseline and at 1 month after radiotherapy. Dysphagia parameter scores were calculated at each exam after liquid (L) and semi-liquid (SL) bolus intake: pre-deglutition penetration, aspiration, pharyngeal transit time (PTT) and hypopharyngeal retention index (HPRI). Overall, 20 patients (6 nasophaynx and 14 oropharynx) completed treatment and instrumental assessment after 1 month. Comparison between pre- and post-treatment HPRI score values showed a significant worsening in both FEES-L (p = 0.021) and SL (p = 0.02) and at VFS-L (p = 0.008) and SL (p = 0.005). Moreover, a relationship between HPRI worsening at FEES-L and FEES-SL (p = 0.005) as well as at VFS-L and VFS-SL (p < 0.001) was observed. PTT was not significantly affected by radiotherapy (p > 0.2). Only a few patients experienced pre-deglutition penetration (1 patient with base of tongue cancer at FEES-L and SL) and aspiration (1 patient with nasopharynx cancer at OPES-L and FEES-SL) after radiotherapy. Our early results showed that IMRT-SWOARs sparing caused a significant increase in the post-deglutition HPRI score. Longer follow-up will be necessary to evaluate if the increase of HPRI is related to a high risk of developing late aspiration.


Subject(s)
Deglutition , Nasopharyngeal Neoplasms/physiopathology , Nasopharyngeal Neoplasms/radiotherapy , Oropharyngeal Neoplasms/physiopathology , Oropharyngeal Neoplasms/radiotherapy , Radiotherapy, Intensity-Modulated , Acute Disease , Adult , Aged , Deglutition Disorders/etiology , Female , Humans , Male , Middle Aged , Nasopharyngeal Neoplasms/drug therapy , Oropharyngeal Neoplasms/drug therapy , Postoperative Complications/etiology , Prospective Studies , Time Factors
2.
G Ital Med Lav Ergon ; 34(3 Suppl): 571-3, 2012.
Article in Italian | MEDLINE | ID: mdl-23405719

ABSTRACT

Exposure to asbestos is the predominant cause of pleural mesothelioma (PM). The PM is a tumor difficult to diagnose, chemoresistant, and with rising Incidence. The long latency periods and the lack of preventive and therapeutic strategies for the MP, suggest that asbestos will be a social and health issue in the near future. Therefore, this overview focuses on current knowledge of epigenetic alterations and on the key role of microRNAs, small RNAs that negatively regulate gene expression, as biomarkers in PM development. Dysregulated microRNA expression pattern is specific for different cancers, including MP. MicroRNA expression analysis is a promising tool for diagnosis, typing of MP than normal tissue and other lung tumors and monitoring of new therapies. However, a better knowledge of miRNA signatures in PM is still necessary to verify the contribution of specific miRNAs as diagnostic biomarkers, also compared to different asbestos forms, exposure and subject work history.


Subject(s)
Asbestos/adverse effects , Environmental Monitoring/methods , MicroRNAs/analysis , Occupational Exposure/adverse effects , Biomarkers/analysis , Humans
3.
G Chir ; 31(8-9): 375-8, 2010.
Article in Italian | MEDLINE | ID: mdl-20843440

ABSTRACT

A case of long-term survivor 50-year-old man treated for advanced gastric cancer with two liver metastases is described. Patient underwent a total gastrectomy with D2 lymphadenectomy and atipic liver resection. After surgery, chemotherapy with PELF achieved a complete clinical response; six month from the fourth cycle, Ca19.9 levels slowly increased until 185 U/mL and a retro-peritoneal lymphadenopathy was detected by US. Three different chemotherapeutic combinations (FOLFOX, FOLFIRI, FOLFOX4) was administrated but two new liver recurrences spread out. From November 2007 until now, patient received 8 CDF cycles and he obtained a complete clinical response supported by persistent negativity of TC-PET scans. The radiological investigations performed after last admission in our Department for jaundice, revealed multiple liver lesions with Ca 19.9 levels of 6.766 U/mL. The patient required placement of metallic biliary endoprosthesis. He is still alive 41 month after primary surgery. We consider this case a successful example of survival increasing by integrated surgery-chemotherapy treatment but also an expression of the failure of current available therapy in the definitive cure for gastric cancer. Metastatic gastric cancer should be considered a disease treatable but not curable.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gastrectomy , Hepatectomy , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Stomach Neoplasms/drug therapy , Stomach Neoplasms/surgery , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Camptothecin/administration & dosage , Camptothecin/analogs & derivatives , Cisplatin/administration & dosage , Epirubicin/administration & dosage , Fluorouracil/administration & dosage , Humans , Leucovorin/administration & dosage , Liver Neoplasms/secondary , Lymph Node Excision , Male , Middle Aged , Organoplatinum Compounds/administration & dosage , Quality of Life , Stomach Neoplasms/pathology , Survivors , Treatment Outcome
5.
Mult Scler ; 15(7): 779-88, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19542262

ABSTRACT

BACKGROUND: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association between cognitive impairment and magnetic resonance imaging (MRI) disease measures in patients with relapsing-remitting (RR) MS is unclear. OBJECTIVES: To study the prevalence of cognitive impairment and its relation with MRI disease measures in mildly disabled patients with RRMS. METHODS: Patients aged 18-50 years with RRMS (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score or=3 cognitive tests) was present in approximately 20% of all patients and in the subgroup who underwent MRI. T2 hyperintense and T1 hypointense lesion volumes were significantly higher in patients with cognitive impairment (defined as impaired performance on at least three tests of the Rao's battery) than those without. EDSS score was also significantly higher in cognitively impaired than in cognitively preserved patients. Disease duration, depression, and years in formal education did not differ significantly between cognitively impaired and cognitively preserved patients. T2 lesion volume, performance intelligence quotient, and age were significant predictors of cognitive impairment in this population. Weak correlations were found between performance on individual cognitive tests and specific MRI measures, with T1 and T2 lesion volumes correlating with performance on most cognitive tests. CONCLUSIONS: Cognitive impairment occurs in approximately one-fifth of mildly disabled patients with MS and is associated with specific MRI disease measures. Assessment of cognitive function at diagnosis could facilitate the identification of patients who may benefit from therapeutic intervention with disease-modifying therapies to prevent further lesion development.


Subject(s)
Cognition Disorders/diagnosis , Disability Evaluation , Magnetic Resonance Imaging , Multiple Sclerosis, Relapsing-Remitting/psychology , Neurologic Examination , Neuropsychological Tests , Adolescent , Adult , Age Factors , Cognition , Cognition Disorders/epidemiology , Cognition Disorders/etiology , Cross-Sectional Studies , Female , Humans , Immunologic Factors/therapeutic use , Intelligence , Interferon-beta/therapeutic use , Italy/epidemiology , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Multiple Sclerosis, Relapsing-Remitting/epidemiology , Odds Ratio , Predictive Value of Tests , Prevalence , Prospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Treatment Outcome , Young Adult
6.
G Chir ; 21(1-2): 49-52, 2000.
Article in Italian | MEDLINE | ID: mdl-10732382

ABSTRACT

After a review of literature and the report of a case with intrathoracic location, the authors consider present criteria for a correct diagnosis of low grade soft tissue sarcoma, when the possibility of nodular fasciitis is under evaluation. Nodular fasciitis is a benign pathology up to day not well characterised from the clinical and pathological point of view. The authors conclude that differential diagnosis between low grade soft tissue sarcoma and nodular fasciitis is frequently possible only on the basis of clinical course evaluation; otherwise the management may be inadequate.


Subject(s)
Fasciitis/diagnosis , Sarcoma/diagnosis , Soft Tissue Neoplasms/diagnosis , Thoracic Neoplasms/diagnosis , Adult , Chemotherapy, Adjuvant , Chronic Disease , Diagnosis, Differential , Fasciitis/drug therapy , Fasciitis/pathology , Fasciitis/surgery , Female , Follow-Up Studies , Humans , Recurrence
7.
G Chir ; 19(5): 223-6, 1998 May.
Article in Italian | MEDLINE | ID: mdl-9677775

ABSTRACT

The Authors report a case of great desmoid tumor of the abdominal wall with intestinal adhesions and enterocutaneous fistula, in a patient with Gardner's syndrome, who underwent total colectomy with ileorectal anastomosis. The patient was treated at first with non steroidal antiinflammatory drugs, then with local chemotherapy. The Authors performed a second surgical procedure resecting the tumor and opening a temporary ileostomy. Despite of these treatment patient showed a local recurrence. Desmoid tumor is a neoplastic benign lesion arising from aponeurotic muscle tissue. Local infiltration and post-operative recurrence are very common. Several surgical and medical treatments are proposed, but they are not totally effective. Surgical treatment might be radical, with wide resection to reduce local recurrences. Radiotherapy and chemotherapy are second choice treatments.


Subject(s)
Abdominal Muscles , Adenomatous Polyposis Coli/complications , Fibromatosis, Aggressive/complications , Adenomatous Polyposis Coli/surgery , Adult , Cutaneous Fistula/complications , Cutaneous Fistula/surgery , Fibromatosis, Aggressive/pathology , Fibromatosis, Aggressive/surgery , Humans , Intestinal Fistula/complications , Intestinal Fistula/surgery , Male
8.
G Chir ; 19(4): 161-3, 1998 Apr.
Article in Italian | MEDLINE | ID: mdl-9628065

ABSTRACT

The Authors report a case of prostatic carcinoma in a 84 year old male, treated with cyproterone acetate (CPA), complicated by a fatal fulminant hepatitis. He was admitted with a mixed jaundice followed by a derange of all liver function tests. Serological markers for hepatitis were negative. Ultrasonography and CT revealed no hepatic abnormality but gallstones and dilatation of principal bile duct with a terminal stricture. By the endoscopic retrograde cholangiography and sphincterotomy we put an external drain tube. He died 9 days after admission. Fatal hepatis due to CPA is a very rare complication but all patients on anti-androgenic drugs should have liver function closely monitored. CPA must be discontinued immediately at the first derange of liver function tests.


Subject(s)
Antineoplastic Agents/adverse effects , Chemical and Drug Induced Liver Injury/etiology , Cyproterone Acetate/adverse effects , Acute Disease , Aged , Aged, 80 and over , Chemical and Drug Induced Liver Injury/diagnosis , Chemical and Drug Induced Liver Injury/mortality , Cholangiopancreatography, Endoscopic Retrograde , Humans , Liver/pathology , Liver Function Tests , Male , Necrosis , Prostatic Neoplasms/drug therapy , Time Factors
9.
G Chir ; 18(4): 209-11, 1997 Apr.
Article in Italian | MEDLINE | ID: mdl-9303635

ABSTRACT

Gaucher's disease is a rare metabolic disorder characterized by the lack of beta-glucocerebrosidase enzyme. In this case report a 26-year-old male patient was, first diagnosed as having splenomegaly and a huge haemangioma, therefore managed by total splenectomy. Histologic examination and specific colouring techniques using PAS and Black Sudan dyes allowed the diagnosis of Gaucher's disease. Preoperative diagnosis is hence fundamental to establish the correct management procedure, which currently may be surgical or medical and/or combined. In fact, following the diagnosis the second step includes the decision-making about splenectomy. Other therapeutic approaches are enzyme replacement therapy and genic therapy. The first may be combined to partial splenectomy, while the latter still needs further evaluations.


Subject(s)
Gaucher Disease/surgery , Splenectomy , Adult , Gaucher Disease/complications , Gaucher Disease/pathology , Hemangioma, Cavernous/complications , Hemangioma, Cavernous/pathology , Hemangioma, Cavernous/surgery , Humans , Male , Spleen/pathology , Splenic Neoplasms/complications , Splenic Neoplasms/pathology , Splenic Neoplasms/surgery , Splenomegaly/complications , Splenomegaly/pathology , Splenomegaly/surgery
10.
Ital J Biochem ; 35(5): 328-32, 1986.
Article in English | MEDLINE | ID: mdl-3542896

ABSTRACT

In this paper are described the immunological and molecular procedures that have allowed the identification and the nucleotide sequence characterization of recombinant cDNA coding for factor XII of human coagulation and have suggested the possible identification of other cDNA clones as coding for factor VII of human coagulation.


Subject(s)
Blood Coagulation , DNA, Recombinant/isolation & purification , Factor VII/genetics , Factor XII/genetics , Genetic Code , Base Sequence , Collodion , DNA, Recombinant/biosynthesis , Electrophoresis, Polyacrylamide Gel , Humans , Immunoenzyme Techniques , Paper , Protein Biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...